AB1423 USE OF BIOSIMILAR THERAPIES IN ADULT PATIENTS DIAGNOSED WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE SPANISH REGISTRY OF ADVERSE EVENTS WITH BIOLOGIC THERAPIES (BIOBADASER)

Abstract

BackgroundJuvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in childhood. The emergence of new biological drugs has changed the prognosis and therapeutic approach to these patients, and...